Analyst Recommendation for Transition Therapeutics Inc. (TTH)

Company

Financials

Insiders

Filings

Analyst

Earnings

Historical

Symbol:

Analyst Information for Transition Therapeutics Inc.

Consensus Rating Average

Consensus Rating for TTH:CA is STRONG BUY

Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).

Rating Scale

	Strong Buy	1.0 - 1.5
	Moderate Buy	1.6 - 2.5
	Hold	2.6 - 3.5
	Moderate Sell	3.6 - 4.5
	Strong Sell	4.6 - 5.0

Consensus Rating Details

Current Average Recommendation	1.50
Previous Average Recommendation	1.60
Change in Average Recommendation	-0.10
Number of Analysts Reporting	5

Strong Buy
1.0

Current: 1.50

Previous: 1.60

Change: -0.10

Strong Sell
5.0

Consensus Rating Industry Comparison

Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations	194
Rank Recommendation relative to companies in its industry	75

Ranked 75 in Industry

1194 MED-BIOMED/GENE

Analyst Recommendations

Analysts recommending Strong Buy	2
Analysts recommending Moderate Buy	3
Analysts recommending Hold	0
Analysts recommending Moderate Sell	0
Analysts recommending Strong Sell	0

Recommendations History

	Current	1 Month Ago	2 Months Ago	3 Months Ago
Strong Buy	2	1	1	1
Moderate Buy	3	4	4	4
Hold	0	0	0	0
Moderate Sell	0	0	0	0
Strong Sell	0	0	0	0
Mean Rec.	1.50	1.60	1.60	1.60

Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT = Realtime, EOD = End Of Day, PD = Previous Day. Market Data powered by QuoteMedia, analyst ratings by Zacks. Terms of Use.